Literature DB >> 21962416

Activity with ambulation attenuates diuretic responsiveness in chronic heart failure.

Paul J Galiwango1, Andrew McReynolds, Joan Ivanov, Chris T Chan, John S Floras.   

Abstract

INTRODUCTION: We hypothesized that discharged heart failure (HF) patients could develop clinical congestion despite adhering to prescribed diuretics, because ambulation attenuates diuretic and natriuretic responsiveness.
METHODS: We studied 9 patients aged 57 ± 13 (mean ± SD) years with New York Heart Association functional class II-III symptoms and ejection fraction <40% (28 ± 7%) and receiving furosemide (≥80 mg/d [113 ± 53 mg/d]) plus renin-angiotensin system antagonists and beta-blockade. Inulin and p-amminohippuric acid were infused to estimate glomerular filtration rate (GFR) and renal plasma flow (RPF). Furosemide was administered intravenously at 75% of the usual oral morning dose. Participants were randomized to supine (90 minutes recumbancy) or upright (90 minutes sitting and treadmill walking) posture and assumed the other position on their second day. Primary outcome variables were urine volume and sodium excretion 90 minutes after furosemide.
RESULTS: On the upright, compared with the supine, day, urine volume (792 ± 484 vs 1,290 ± 503 mL; P = .02) and sodium (79 ± 55 vs 141 ± 61 mmol; P < .01) were attenuated, whereas plasma norepinephrine (4.4 ± 2.7 vs 2.3 ± 1.8 mmol/L; P = .01) and renin (327 ± 250% of supine; P < .01) were augmented. Urinary K+, mean pressure, GFR, and RPF were similar.
CONCLUSIONS: Activation of the sympathetic nervous system and renin-angiotensin axis by upright ambulation may attenuate diuresis and natriuresis by increasing proximal tubular reabsorption of sodium and water.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21962416     DOI: 10.1016/j.cardfail.2011.06.652

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  2 in total

Review 1.  The role of renal denervation in the treatment of heart failure.

Authors:  Paul A Sobotka; Henry Krum; Michael Böhm; Darrel P Francis; Markus P Schlaich
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

Review 2.  Baroreflex activation therapy: a new approach to the management of advanced heart failure with reduced ejection fraction.

Authors:  Edoardo Gronda; Darrel Francis; Faiez Zannad; Christian Hamm; Josep Brugada; Emilio Vanoli
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2017-09       Impact factor: 2.160

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.